Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,388 | -25,793 | -13,604 | -50,514 | -37,268 |
| Depreciation Amortization | -35 | 81 | 3 | 625 | 656 |
| Accounts receivable | 12 | 12 | 11 | 234 | 176 |
| Accounts payable and accrued liabilities | -1,278 | -499 | -431 | 1,760 | 944 |
| Other Working Capital | -2,858 | -2,064 | -2,091 | 1,717 | 1,244 |
| Other Operating Activity | 5,353 | 3,096 | 1,694 | 2,076 | 1,896 |
| Operating Cash Flow | $-37,193 | $-25,167 | $-14,418 | $-44,101 | $-32,353 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 33,250 | 28,250 | 19,000 | 92,678 | 72,078 |
| PPE Investments | -172 | -115 | -28 | -743 | -673 |
| Purchase Of Investment | -28,915 | N/A | N/A | -50,105 | -37,726 |
| Investing Cash Flow | $4,164 | $28,135 | $18,972 | $41,831 | $33,679 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 28,637 | 28,616 | 239 | 300 | 258 |
| Other Financing Activity | -204 | -204 | 0 | -281 | -55 |
| Financing Cash Flow | $28,433 | $28,412 | $239 | $19 | $204 |
| Beginning Cash Position | 72,637 | 72,637 | 72,637 | 74,888 | 74,888 |
| End Cash Position | 68,040 | 104,018 | 77,430 | 72,637 | 76,418 |
| Net Cash Flow | $-4,597 | $31,381 | $4,793 | $-2,251 | $1,530 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,193 | -25,167 | -14,418 | -44,101 | -32,353 |
| Capital Expenditure | -172 | -115 | -28 | -743 | -673 |
| Free Cash Flow | -37,365 | -25,281 | -14,446 | -44,844 | -33,026 |